Fmoc-N-Me-Nle-OH,
112883-42-8,
Fmoc-N-methyl-L-norleucine,
Fmoc-Nalpha-methyl-L-norleucine,
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hexanoic acid,
MFCD00235878,
L-Norleucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-,
N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-ALPHA-METHYL-L-NORLEUCINE,
AK-85719,
L-Norleucine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-,
SCHEMBL119776,
TMA044,
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hexanoic acid,
CTK4A8010,
DTXSID00427132,
KS-00000GB7,
ZINC2560005,
CF-828,
AKOS015837161,
CS-W008492,
FCH2721616,
RTR-062402,
AJ-40413,
DS-18101,
SC-89920,
AX8131370,
TR-062402,
Fmoc-N-Me-Nle-OH, >=96.0% (HPLC),
FT-0689530,
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-norleucine,
N-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-N-methyl-L-norleucine,
(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]hexanoic acid,
(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}hexanoic acid,
Fmoc-L-2-aminovaleric acid,
Fmoc-N-Me-Nle-OH - 1G 1g,
CID7019522,
A7651,
2-(9H-fluoren-9-ylmethoxycarbonyl-methyl-amino)hexanoic Acid,
1217482-47-7,